Researchers examined the relationship between migraines and the risk of perioperative ischemic stroke and hospital readmission within 30 days after surgery.
Chronic cluster headache is the most disabling form of cluster headache, and current treatment options are not very effective. For this study, researchers evaluated whether sphenopalatine ganglion...
Researchers conducted a phase 2/3 randomized clinical trial to better understand the effects of a calcitonin gene-related peptide receptor antagonist for the prevention of migraine.
A recent study found that rimegepant, an orally administered calcitonin gene-related peptide receptor antagonist, is safe and well-tolerated for up to 52 weeks in individuals with migraine, with no signs of...
